Clinical Trial Update: The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy [Phase 3]

View source ↗

Summary

Phase 3 results from the Asia-Pacific flexible-dose study of dapoxetine for premature ejaculation have been posted after completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation
• Sexual Dysfunction

Drugs mentioned

• Dapoxetine (dapoxetine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Sexual Dysfunction, Physiological | Phase 3 | Status: COMPLETED | Results posted: 2012-10-31